lily glp-1 Eli Lilly's oral for type 2 diabetes submission in the U.S Eli Lilly's New GLP‑1 Pill

Additionally, healthcare systems are investing in digital pharmacy technologies to support patient convenience and medication adherence improvement

Diabetics should coordinate any peptide use with their healthcare team

ShortWDRaeMLuTPadonBPrajapatiTJFarukFet al

Take home message Wegovy and Mounjaro are effective for managing obesity, but theyre not suitable for everyone

Editor information Editors and Affiliations Rights and permissions Copyright information 2022 Springer Nature Switzerland AG About this entry Cite this entry Carmo de Carvalho e Martins, M.d., da Silva Santos Oliveira, A.S., da Silva, L.A.A., Primo, M.G.S., de Carvalho Lira, V.B